From: The national economic burden of rare disease in the United States in 2019
Ā | Total excess medical cost due to RD | Per-person (2019 $) | |
---|---|---|---|
(in Million $) | Percentage of the total (%) | ||
Age | Ā | Ā | Ā |
Ā <ā18 | 42,381 | 9.4 | 32,037 |
Ā 18ā64 | 248,198 | 55.2 | 29,647 |
Ā ā„ā65 | 158,884 | 35.3 | 27,157 |
Insurance | Ā | Ā | Ā |
Ā Medicaid | 43,621 | 9.7 | 27,573 |
Ā Commercial | 213,094 | 47.4 | 29,910 |
Ā Medicare | 192,747 | 42.9 | 28,185 |
Type of service | Ā | Ā | Ā |
Ā Inpatient | 143,000 | 31.8 | 9199 |
Ā Prescription medication | 79,466 | 17.7 | 5112 |
Ā Outpatient | 62,032 | 13.8 | 3990 |
Ā Other ancillary | 48,974 | 10.9 | 3150 |
Ā Outpatient prescription administration | 47,567 | 10.6 | 3060 |
Ā Physician | 31,372 | 7.0 | 2018 |
Ā Non-acute inpatient | 30,759 | 6.8 | 1979 |
Ā Durable medical equipment | 4,401 | 1.0 | 283 |
Ā Caregiver | 1890 | 0.4 | 122 |
Overall | 449,462 | 100 | 28,913 |